UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.860

Sortiert nach

The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long‐term nucleos(t)ide analogue therapy

Alimentary pharmacology & therapeutics, 2014-12, Vol.40 (11-12), p.1262-1269

2014

Link zum Volltext

Verfügbarkeit prüfen

Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2010-01, Vol.31 (1), p.20-34

2010

Link zum Volltext

Verfügbarkeit prüfen

Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals

PloS one, 2015-09, Vol.10 (9), p.e0137568-e0137568

2015

Link zum Volltext

Verfügbarkeit prüfen

Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV‐HBV Coinfected Transplant Recipients

American journal of transplantation, 2010-05, Vol.10 (5), p.1268-1275

2010

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy

Journal of viral hepatitis, 2011-06, Vol.18 (6), p.415-423

2011

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (6), p.599-604

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region

Journal of viral hepatitis, 2016-01, Vol.23 (1), p.15-22

2016

Link zum Volltext

Verfügbarkeit prüfen

Editorial: anti‐viral therapy for prevention of perinatal HBV transmission – extending therapy beyond birth and the risk of post‐partum flare

Alimentary pharmacology & therapeutics, 2014-07, Vol.40 (1), p.115-116

2014

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus (HBV) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (CHB) disease phases

Journal of viral hepatitis, 2015-04, Vol.22 (4), p.416-426

2015

Link zum Volltext

Verfügbarkeit prüfen

Deep sequencing shows low‐level oncogenic hepatitis B virus variants persists post–liver transplant despite potent anti‐HBV prophylaxis

Journal of viral hepatitis, 2018-06, Vol.25 (6), p.724-732

2018

Link zum Volltext

Verfügbarkeit prüfen

Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients

Journal of clinical virology, 2013-06, Vol.57 (2), p.103-108

2013

Link zum Volltext

Verfügbarkeit prüfen

Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis

Hepatology (Baltimore, Md.), 1999-03, Vol.29 (3), p.928-938

1999

Link zum Volltext

Verfügbarkeit prüfen

Letter: lipid‐lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B—more evidence is needed. Authors’ reply

Alimentary pharmacology & therapeutics, 2017-10, Vol.46 (8), p.770-771

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus

Journal of viral hepatitis, 2012-02, Vol.19 (2), p.103-111

2012

Link zum Volltext

Verfügbarkeit prüfen

Low Doses of Hepadnavirus Induce Infection of the Lymphatic System That Does Not Engage the Liver

Journal of Virology, 2004-02, Vol.78 (4), p.1730-1738

2004

Link zum Volltext

Verfügbarkeit prüfen

Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis

The Journal of clinical investigation, 1999-07, Vol.104 (2), p.203-212

1999

Link zum Volltext

Verfügbarkeit prüfen

Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells

Journal of general virology, 2005-03, Vol.86 (3), p.657-666

2005

Link zum Volltext

Verfügbarkeit prüfen

A241 CHARACTERIZING KUPFFER CELL-VIRUS INTERACTIONS IMMEDIATELY FOLLOWING VIRAL INVASION AND IN ACUTE HEPATITIS IN THE WOODCHUCK HEPATITIS VIRUS MODEL OF HEPATITIS B VIRUS INFECTIONS

Journal of the Canadian Association of Gastroenterology, 2023-03, Vol.6 (Supplement_1), p.69-70

2023

Link zum Volltext

Verfügbarkeit prüfen

Management of hepatitis C virus and human immunodeficiency virus coinfection

Minerva gastroenterologica e dietologica, 2014-09, Vol.60 (3), p.165

2014

Link zum Volltext

Verfügbarkeit prüfen

A182 HEPATOCELLULAR CARCINOMA (HCC) SCREENING PRACTICES IN CHRONIC HEPATITIS B (HBV) AMONG CANADIAN GASTROENTEROLOGISTS AND HEPATOLOGISTS: AN ONLINE SURVEY

Journal of the Canadian Association of Gastroenterology, 2018-03, Vol.1 (suppl_1), p.316-317

2018

Link zum Volltext

Verfügbarkeit prüfen

A340 IDENTIFICATION OF A G4-QUADRUPLEX STRUCTURE MOTIF IN HEPATITIS B VIRUS GENOME: A POTENTIAL NOVEL DRUG TARGET

Journal of the Canadian Association of Gastroenterology, 2018-03, Vol.1 (suppl_2), p.491-492

2018

Link zum Volltext

Verfügbarkeit prüfen

Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1

PloS one, 2015-09, Vol.10 (9)

2015

Link zum Volltext

Verfügbarkeit prüfen

Detection of Hepatitis B Virus and HBV Co-Infected Individuals

PloS one, 2015-09, Vol.10 (9)

2015

Link zum Volltext

Verfügbarkeit prüfen

A217 TREATMENT ADHERENCE OF CHRONIC HEPATITIS B PATIENTS WITH HEPATOCELLULAR CARCINOMA FROM THE CANHEPB NETWORK

Journal of the Canadian Association of Gastroenterology, 2022-02, Vol.5 (Supplement_1), p.106-107

2022

Link zum Volltext

Verfügbarkeit prüfen

A202 IMPACT OF THE COVID-19 PANDEMIC ON THE EPIDEMIOLOGY OF ALCOHOL-RELATED HEPATITIS

Journal of the Canadian Association of Gastroenterology, 2022-02, Vol.5 (Supplement_1), p.87-88

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.860

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.487)
Mit Volltextzugriff
(1.626)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.549)
Französisch
(308)
Japanisch
(143)
Russisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long‐term nucleos(t)ide analogue therapy

Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease

Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals

Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV‐HBV Coinfected Transplant Recipients

Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy

Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers

Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region

Editorial: anti‐viral therapy for prevention of perinatal HBV transmission – extending therapy beyond birth and the risk of post‐partum flare

Hepatitis B virus (HBV) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (CHB) disease phases

Deep sequencing shows low‐level oncogenic hepatitis B virus variants persists post–liver transplant despite potent anti‐HBV prophylaxis

Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients

Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis

Letter: lipid‐lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B—more evidence is needed. Authors’ reply

Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus

Low Doses of Hepadnavirus Induce Infection of the Lymphatic System That Does Not Engage the Liver

Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis

Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells

A241 CHARACTERIZING KUPFFER CELL-VIRUS INTERACTIONS IMMEDIATELY FOLLOWING VIRAL INVASION AND IN ACUTE HEPATITIS IN THE WOODCHUCK HEPATITIS VIRUS MODEL OF HEPATITIS B VIRUS INFECTIONS

Management of hepatitis C virus and human immunodeficiency virus coinfection

A182 HEPATOCELLULAR CARCINOMA (HCC) SCREENING PRACTICES IN CHRONIC HEPATITIS B (HBV) AMONG CANADIAN GASTROENTEROLOGISTS AND HEPATOLOGISTS: AN ONLINE SURVEY

A340 IDENTIFICATION OF A G4-QUADRUPLEX STRUCTURE MOTIF IN HEPATITIS B VIRUS GENOME: A POTENTIAL NOVEL DRUG TARGET

Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1

Detection of Hepatitis B Virus and HBV Co-Infected Individuals

A217 TREATMENT ADHERENCE OF CHRONIC HEPATITIS B PATIENTS WITH HEPATOCELLULAR CARCINOMA FROM THE CANHEPB NETWORK

A202 IMPACT OF THE COVID-19 PANDEMIC ON THE EPIDEMIOLOGY OF ALCOHOL-RELATED HEPATITIS

Suchergebnisse filtern